Unlike existing photoimmunotherapy strategies that primarily focus on promoting anti‐cancer immune cells, AuNH‐2‐Ab can regulate the TIME by inhibiting PD‐L1+ TAMs, thereby facilitating the cancer‐immunity cycle to maximize the effect of photoimmunotherapy. Here, CD274 is linked to cancer.